Risk factors related to the prognosis for HCC patients with PVTT include age, sex, tumor size and number, HBsAg, AFP level, Child‐Pugh class, cirrhosis, PVTT type, with/without TACE, and treatment. The gene discussed is AFP; the disease is hepatocellular carcinoma.